Alpha-Beta Arteether Injection 75 MG/1 ML, 150 MG/ML, 225 MG/3 ML

Alpha-Beta Arteether Injection 75 MG/1 ML, 150 MG/ML, 225 MG/3 ML - Image 2

Category:Antimalarial SKU: 00003-103

Alpha-Beta Arteether Injection 75 MG/1 ML, 150 MG/ML, 225 MG/3 ML

Download as PDF

Enquire Now

Add to Compare

Description
Reviews (0)

Description

PRODUCT DESCRIPTION:

Alpha-Beta Arteether is a powerful oil-based artemisinin derivative used for the treatment of severe malaria caused by Plasmodium falciparum. It acts rapidly by interfering with the parasite’s protein synthesis and membrane function, leading to a quick reduction in parasitemia.

Its prolonged half-life allows for once-daily administration, offering better compliance and therapeutic advantage in clinical and rural healthcare setups.

Formulated as a clear, sterile solution, Alpha-Beta Arteether Injection provides an effective and fast-acting treatment in cases where oral therapy is not feasible or advisable.

The product is manufactured under stringent GMP compliance, ensuring safety, efficacy, and global regulatory alignment.

Formulation & Presentation:

Dosage Form: Sterile Injectable (Sterile Lyophilized Solution for Reconstitution)
Presentation: Amber Glass Vial (customizable as per market demand)
Available Strengths:
- Alpha-Beta Arteether: 75 MG/ ML Vial
- Alpha-Beta Arteether: 150 MG/ ML Vial
- Alpha-Beta Arteether: 225 MG/ ML Vial
Route of Administration: Intramuscular (IM) after appropriate reconstitution or as per clinical indication and severity. Reconstituted as per protocol for injection in country of use. To be administered under strict supervision of a qualified doctor or as per physician’s discretion or decision only.

Therapeutic Indications:

Treatment of Plasmodium falciparum malaria in moderate to severe cases
Especially recommended in high-endemic zones and resistant malaria strains
Suitable when oral antimalarials are contraindicated or unavailable

Side Effects:

COMMON:
- Local pain or swelling at injection site
- Fever
- Headache
- Body ache
- Dizziness
SERIOUS (RARE):
- Neurotoxicity (tremors, confusion)
- Hepatic dysfunction
- Hypersensitivity reactions
- QT prolongation (rare cardiac toxicity)
PRECAUTIONS:
- Not recommended during the first trimester of pregnancy
- Use with caution in patients with liver dysfunction
- Monitor neurological symptoms in prolonged therapy
- Should be administered by qualified healthcare professionals only

Reviews

There are no reviews yet.

Be the first to review “Alpha-Beta Arteether Injection 75 MG/1 ML, 150 MG/ML, 225 MG/3 ML” Cancel reply

TECHNICAL INFORMATION

Product Specifications

HSN Code: To be assigned per international classification standards & import jurisdiction
Weight: Approx. 40g per carton (with packaging)
Dimensions: 15 x 1 x 8 CMS
Shelf Life: 24–36 months under recommended storage conditions from date of manufacture (subject to country-specific guidelines)
Storage:
- Store below 25°C (Do not freeze)
- Lyophilized vial to be stored at room temperature below 25°C
- No cold-chain logistics required
- Protect from moisture and direct sunlight

Regulatory Status & Supply Information

Regulatory Status: WHO-GMP Compliant Manufacturing
Documentation: COA, MSDS, Stability Data, Manufacturing Batch Record, Dossier Support (on request)
Export Dossiers: COA, COPP, Dossier Available (CTD/eCTD formats)
Standards: Complies with USP/EP/BP
Stability: Compliant
MOQ: Negotiable, based on market & registration status
Export Options: Available for private label, institutional supply, or branded export

Who Should Source This Product?

Public health authorities managing malaria treatment programs in endemic countries
NGOs & non-profits operating mobile clinics or emergency care in malaria-affected regions
Hospitals & clinics in Africa, Asia, and South America requiring injectable antimalarials
International aid agencies & importers seeking reliable sources for artemisinin-based therapies
Distributors involved in national malaria eradication campaigns and donor-funded projects